Results
21
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
21 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €6.12 | -6.1% | 13.1% | €92.1m | €6.30 | PS15.2x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €18.92 | -1.9% | -25.2% | €156.3m | €30.30 | PE20.7x | E39.4% | n/a | Capital Goods | ||
VU | €131.80 | -6.5% | -3.2% | €2.1b | €195.20 | PE26.3x | E24.3% | 0.2% | Tech | ||
OSE | €6.54 | -4.2% | 96.4% | €142.3m | €10.15 | PS63.9x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €28.50 | -2.6% | -27.7% | €149.1m | €60.33 | PE19x | E31.8% | n/a | Energy | ||
ALMUN | €0.50 | 4.0% | -80.4% | €4.4m | €1.30 | PB0.4x | E149.2% | n/a | Tech | ||
ALCUR | €6.58 | -2.1% | 160.1% | €37.9m | €8.48 | PE21.1x | E27.5% | n/a | Capital Goods | ||
MEDCL | €15.94 | 7.6% | 151.8% | €463.2m | €20.70 | PS38.8x | E69.6% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €4.22 | 6.0% | 67.5% | €22.0m | €5.80 | PE20.8x | E35.2% | n/a | Healthcare | ||
ALSTI | €17.80 | -5.8% | n/a | €90.5m | €16.50 | PE45.3x | E28.5% | 1.1% | Capital Goods | ||
ALLIX | €7.81 | 22.0% | -26.6% | €50.8m | €13.50 | PS1.5x | E102.1% | n/a | Software | ||
S30 | €1.66 | -3.5% | -47.4% | €177.5m | €2.50 | PB1.6x | E103.4% | n/a | Software | ||
ALECP | €0.35 | 0% | -33.5% | €43.1m | n/a | PE47.9x | E86.8% | 0% | Media | ||
ALHOP | €23.50 | 7.3% | 35.1% | €67.5m | €30.05 | PE14.8x | E21.6% | 2.8% | Media | ||
ATEME | €3.85 | -3.8% | -59.6% | €44.2m | €8.00 | PB1.2x | E96.4% | n/a | Tech | ||
ALCIS | €8.50 | -0.9% | -18.7% | €66.2m | €12.10 | PE20.8x | E56.5% | 1.9% | Commercial Services | ||
OVH | €5.54 | -2.9% | -46.1% | €1.1b | €8.61 | PS1.1x | E101.1% | n/a | Software | ||
LSS | €28.25 | -2.2% | 4.1% | €1.1b | €34.75 | PE32x | E28.6% | 1.3% | Software | ||
ALPAT | €16.40 | 13.9% | 34.4% | €18.1m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
CLA | €1.76 | -4.6% | 10.4% | €100.1m | €4.75 | PE-20x | E90.6% | n/a | Software | ||
EXN | €23.25 | 0% | 23.0% | €2.1b | €24.61 | PE51.2x | E32.4% | 0% | Software |